ReviewJournal of clinical medicine2024

Efficacy and Safety of Amivantamab in Advanced or Metastatic EGFR-Mutant Non-Small Cell Lung Cancer: A Systematic Review.

Ionas Papassotiriou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.